Introduction: The internet has become a primary source of information on medicines, yet the quality of this information is inconsistent. Despite the proliferation of web-based resources, limited research has specifically examined the reliability of online information on medicines. The variability in quality can be attributed to the recent shift toward digital information-seeking and the absence of specialized tools designed to assess the quality of medication-related information online.
Aim: To evaluate the quality of information about Amitriptyline available on websites using three well-established, generic evaluation tools-HONcode, DISCERN, and JAMA-compared against the domain-specific Keystone action plan criteria.
Methods: Adopting an evaluative research design, this study utilized the aforementioned four assessment tools to collect and analyze data. Four independent assessors were recruited to evaluate the quality of the information on selected websites.
Results: A Google search using "Amitriptyline" identified 30 websites for the study sample. Reliability analysis using Cronbach's alpha, the Inter-Class Correlation coefficient, and Kendall's rank-order correlation coefficient revealed that the Keystone criteria demonstrated the highest internal consistency and reliability compared to DISCERN, HONcode, and JAMA.
Conclusion: This study indicates that the Keystone action plan criteria may serve as a reliable, domain-specific tool for evaluating medicines information on websites. The results underscore the importance of specialized assessment criteria for online medication information, as they provide more consistent and accurate evaluations compared to generic tools.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11891361 | PMC |
http://dx.doi.org/10.3389/fpubh.2025.1460202 | DOI Listing |
Front Public Health
March 2025
Department of Health Informatics, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia.
Introduction: The internet has become a primary source of information on medicines, yet the quality of this information is inconsistent. Despite the proliferation of web-based resources, limited research has specifically examined the reliability of online information on medicines. The variability in quality can be attributed to the recent shift toward digital information-seeking and the absence of specialized tools designed to assess the quality of medication-related information online.
View Article and Find Full Text PDFBMJ Open Qual
March 2025
Quality Assurance and Standardization Division, Eastern Regional Referral Hospital, Mongar, Bhutan.
Introduction: Medication error is one of the most common safety issues and the highest prevalence rate of preventable medication-related harm is seen in low-income and middle-income countries especially in Africa and South Asian countries. Studies done elsewhere show that medication errors related to transcription and drug chart documentation can be as high as 70%. A baseline survey done in our department showed that our drug charting practices and documentation are only complete in 45% which could significantly contribute to medication errors and patient safety.
View Article and Find Full Text PDFIntroduction Refractory vasospastic angina (VSA) includes patients with disabling angina despite maximally tolerated calcium channel blocker and nitrate therapy. Randomised clinical trial evidence confirms the efficacy of cilostazol in refractory VSA, yet its use in real-world clinical practice is limited. This study evaluated the impact of cilostazol therapy on patient-reported outcomes in patients with refractory VSA.
View Article and Find Full Text PDFJ Racial Ethn Health Disparities
February 2025
Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Level 6, 75 Talavera Road, Macquarie Park, Sydney, NSW, 2109, Australia.
Objectives: People from ethnic minority backgrounds are exposed to greater risk of patient safety events (such as healthcare-acquired infections and medication errors) occurring in their healthcare. However, evidence of the type and frequency of patient safety events occurring in cancer care among patients from ethnic minority background is lacking. This study sought to address this evidence gap.
View Article and Find Full Text PDFOral Radiol
February 2025
Department of Medical Radiological Technology, Faculty of Health Sciences, Kyorin University, B-524, 5-4-1 Shimorenjaku, Mitaka, Tokyo, 181-8612, Japan.
Objective: We developed a new phantom for technical evaluation of jawbone single-photon emission computed tomography (SPECT) examinations for medication-related osteonecrosis of the jaw (MRONJ). In this study, we verified the utility of the phantom by determining optimal image reconstruction parameters.
Methods: We evaluated the image quality and quantification in jawbone SPECT images obtained by different reconstruction parameters using the phantom.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!